Dr. Lawrence Petz, Chief Medical Officer at StemCyte(R), Inc., Receives Tibor Greenwalt Memorial Award and Lectureship

ARCADIA, Calif., Oct. 24 /PRNewswire/ -- The AABB announced that Lawrence D. Petz, MD, chief medical officer at StemCyte, Inc., received the Tibor Greenwalt Memorial Award and Lectureship for 2006. According to the AABB, "This award recognizes an individual who made major scientific or clinical contributions to hematology and transfusion medicine and succinctly communicated these advances." Dr. Petz received the award at the AABB annual meeting in Miami, FL, which ends today.

"We are delighted that the AABB has bestowed this important honor upon Dr. Petz," says StemCyte's CEO Ken Giacin. "For years, Dr. Petz has used his expertise in transfusion medicine to help patients around the world. We are proud that Dr. Petz has helped StemCyte establish an excellent record of transplant success." Dr. Petz joined StemCyte in 2000 after serving as Director of Transfusion Medicine and Professor of Pathology & Laboratory Medicine at UCLA Medical Center. Prior to UCLA, Dr. Petz held a number of positions at the City of Hope National Medical Center, including Chairman of the Division of Medicine.

Dr. Petz is the author or editor of several well-known, authoritative textbooks, including Clinical Bone Marrow Transplantation (1983), Clinical Practice of Transfusion Medicine, and the co-author of Immune Hemolytic Anemias. He has received some of the highest honors in transfusion medicine, including the Emily Cooley Award; the Morten Grove-Rasmussen Memorial Award; the Transfusion Medicine Academic Award from National Heart, Lung, and Blood Institute; and the Owen Thomas Award from the California Blood Bank Society. Dr. Petz chairs StemCyte's prestigious Medical Advisory Board. Dr. Petz also serves as executive editor of http://www.cordbloodforum.org/ and as a founder and organizer of the annual International Symposium on Cord Blood Transplantation.

To find out more visit StemCyte online at http://www.stemcyte.com/. About StemCyte, Inc.

StemCyte, Inc., headquartered in Arcadia, California, intends to create the largest donor umbilical cord blood stem cell bank in the world. StemCyte is dedicated to providing high quality, cost-effective, stem cell transplantation and therapy to all patients in need. StemCyte is accredited by AABB, the College of American Pathologists (CAP), and the National Marrow Donor Program (NMDP). Additionally, the StemCyte International Cord Blood Center is accredited by the Foundation for Accreditation of Cellular Therapies (FACT) for cord blood collection, processing, testing, banking, selection and release.

  CONTACT:  David Carmel
            StemCyte, Inc.
            917-414-4121